NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study

Background: Easily accessible biomarkers enabling the identification of those patients with multiple sclerosis (MS) who will accumulate irreversible disability in the long term are essential to guide early therapeutic decisions. We here examine the utility of serum neurofilament light chain (sNfL) f...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Timo Uphaus, Falk Steffen, Muthuraman Muthuraman, Nina Ripfel, Vinzenz Fleischer, Sergiu Groppa, Tobias Ruck, Sven G. Meuth, Refik Pul, Christoph Kleinschnitz, Erik Ellwardt, Julia Loos, Sinah Engel, Frauke Zipp, Stefan Bittner
Format:	Artigo
Sprog:	Inglês
Udgivet:	Elsevier 2021-10-01
Serier:	EBioMedicine
Fag:	Multiple sclerosis Disease progression Neurofilament light chain SPMS transition
Online adgang:	http://www.sciencedirect.com/science/article/pii/S2352396421003832
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!